0001779020 false 0001779020 2021-12-15 2021-12-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares



United States

Securities and Exchange Commission

Washington, D.C. 20549


Form 8-K

Current Report


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): December 15, 2021



(Exact name of registrant as specified in its charter)


Delaware   001-39280   84-1924518

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification Number)


140 Industrial Boulevard

Bainbridge, Georgia

(Address of principal executive offices)   (Zip Code)


Registrant’s telephone number, including area code: (229) 243-7075



(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


  Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common stock, $0.0001 par value per share    DNMR   The New York Stock Exchange






Item 5.07 Submission of Matters to a Vote of Security Holders.


On December 15, 2021, Danimer Scientific, Inc. (the “Company”) held an Annual Meeting of Stockholders. Of the 100,344,315 shares of common stock outstanding and entitled to vote at the Meeting, 71,402,617 shares of common stock were present in person or by proxy and entitled to vote, representing approximately 71.16% of the Company’s shares of common stock entitled to vote at the Meeting.


At the Meeting, the Company’s stockholders: (i) approved the election of each of the following eight director nominees standing for election: Stephen E. Croskrey, John P. Amboian, Richard Hendrix, Christy Basco, Philip Gregory Calhoun, Gregory Hunt, Dr. Isao Noda, and Stuart W. Pratt, and (ii) ratified the appointment of KMPG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021.


The voting results for each proposal are set forth below:


Proposal 1 – To elect eight members to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified:


Name Votes For Votes Withheld



Stephen E. Croskrey 46,366,372 3,717,736 21,318,509
John P. Amboian 37,381,382 12,702,726 21,318,509
Richard Hendrix 38,938,557 11,145,551 21,318,509
Christy Basco 49,531,279 552,829 21,318,509
Philip Gregory Calhoun 42,776,988 7,307,120 21,318,509
Gregory Hunt 46,478,525 3,605,583 21,318,509
Dr. Isao Noda 42,946,722 7,137,386 21,318,509
Stuart W. Pratt 46,240,764 3,843,344 21,318,509


Proposal 2 – To ratify the appointment of KMPG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021:


Votes For Votes Against Votes Abstained



71,226,526 81,365 94,726 0







Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: December 17, 2021


  By: /s/ John A. Dowdy, III
  Name: John A. Dowdy, III
  Title: Chief Financial Officer